Sichuan Gangtong Medical Equipment Group Co., Ltd. Class A

Sichuan Gangtong Medical Equipment Group Co., Ltd. Class A

SSZSE:301515
17.14
CNY
-0.66
(-3.71%)
-0.07EPS
2.05BMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.57
4.27
5.06
4.58
4.8
5.25
6.1
7.5
9.09
10.25
9.86
7.6
7.47
7.72
Basic EPS, GAAP
0.41
0.43
0.5
0.39
0.59
0.32
0.46
0.87
0.96
0.99
0.97
0.15
-0.03
-0.04
Free Cash Flow per Basic Share
- -
- -
0.02
0.13
-0.01
-0.15
-0.2
0.62
0.12
0.57
-1.67
-0.48
-0.36
- -
Dividend per Share
0.47
0.2
0.16
0.06
0.07
0.03
0.11
0.17
0.2
0.09
0.04
0.41
0.19
0.3
Book Value per Share
2.82
3.25
3.65
4.03
4.57
4.55
4.91
5.67
6.45
7.39
13.29
12.85
12.25
12.16
Tangible Book Value per Share
2.71
2.82
3.17
3.55
4.1
4.1
4.47
5.19
5.81
6.76
13.04
12.62
12.03
11.95
Basic Weighted Avg Shares
74
74
74
74
75
75
75
75
75
75
85
99
97
97
Sales/Revenue/Turnover
265
317
376
339
362
394
457
562
681
769
842
754
722
749
Operating Margin (%)
10.94
14.24
14.09
16.33
18.73
11.26
11.79
16
13.76
15.66
13.63
7.49
8.48
4.76
Depreciation Expense
- -
- -
4
5
5
6
7
6
11
10
10
12
13
- -
Net Income, GAAP
30
32
37
29
44
24
35
65
72
74
83
14
-3
-4
Effective Tax Rate (%)
26.58
18.09
16.33
17.84
16.22
11.16
13.22
14.02
12.17
11.25
12.41
4.5
- -
- -
Profit Margin (%)
11.48
10.07
9.88
8.52
12.28
6.06
7.58
11.61
10.52
9.62
9.86
1.91
-0.37
-0.52
Working Capital
166
174
207
230
254
233
242
313
351
425
1,188
1,107
1,019
1,041
LT Debt
- -
25
15
- -
- -
- -
- -
10
7
11
9
14
42
117
Total Equity
212
244
273
302
343
341
368
426
484
554
1,329
1,285
1,223
1,213
Return on Invested Capital (%)
- -
11.4
10.7
8.52
10.07
6.34
12.87
42.68
44.38
24.27
9.96
0.98
- -
- -
Return on Capital (%)
- -
12.47
11.52
8.16
11.63
6.44
10.41
17.39
16.44
13.6
8.28
1.39
- -
- -
Return on Common Equity (%)
- -
14.03
14.38
10.03
13.77
6.98
9.77
16.45
15.76
14.24
8.83
1.1
-0.21
-0.32

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
214
243
200
LT Borrowings
59
97
116
LT Finance Leases
1
5
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
100
100
100
Market Capitalization
2,277
1,753
2,052

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,761
1,807
1,833
Cash, Cash Equivalents & STI
706
767
725
Accounts Receivable, Net
672
676
635
Inventories
321
287
380
Total Current Liabilities
721
753
792
Payables & Accruals
- -
- -
- -
ST Debt
214
243
200
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
20.69%
31.97%
-4.8%
Free Cash Flow
240.23%
-44.18%
-26.5%
Net Income, GAAP
-5.69%
-35.13%
-118.34%
Sales/Revenue/Turnover
7.36%
5.75%
-4.3%
Total Cash Common Dividend
114.45%
183.96%
-53.98%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
76
361
55
262
754
2025
24
241
- -
377
722
2026
50
222
99
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.11
0.05
0.05
-0.06
0.15
2025
0.02
-0.1
- -
0.08
-0.03
2026
-0.01
-0.18
0.07
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.26
0.03
0.12
0.41
2025
0.01
0.02
- -
0.04
0.19
2026
0.01
0.02
0.22
- -
- -

Company Description

CEO
Yong Chen
Full Time Employees
1,086
Sector
Health technology
Industry
Medical specialties
Address
Chengdu China
IPO Date
Jul 25, 2023
Website
gtjt.com
Business
Sichuan Gangtong Medical Equipment Group Co., Ltd. is a China-based company engaged in the research, development, design, manufacturing, integration, and life-cycle maintenance of specialized medical equipment and intelligent healthcare engineering systems. Founded in 1998 and headquartered in Jianyang, Sichuan Province, the company provides turnkey solutions designed to ensure medical gas supply safety, clinical infection control, and digital hospital infrastructure for healthcare institutions. The company operates primarily through two core business segments, Medical Gas Equipment and Systems and Medical Cleanroom Equipment and Systems, alongside expanding digital health and pharmaceutical engineering divisions. Its comprehensive product and service portfolio includes medical central oxygen supply systems, medical central suction and vacuum units, centralized compressed air supply systems, medical molecular sieve oxygen generators, medical gas manifolds, secondary pressure reducing boxes, medical gas alarm panels, and terminal outlet units; modular clean operating room suites, intensive care units, negative-pressure isolation wards, central sterile supply departments, clean air-conditioning systems, intelligent electrical control panels, and modular cleanroom wall systems; integrated digital operating room platforms, smart inpatient ward management solutions, hospital logistics automation systems, and the proprietary Gangtong Cloud Monitoring Platform for remote equipment telemetry and predictive maintenance; pharmaceutical-grade purified water systems, water-for-injection systems, clean steam generators, and disinfection equipment; as well as architectural cleanroom engineering, technical system installation, validation, regulatory compliance testing, and ongoing after-sales maintenance services. Sichuan Gangtong Medical Equipment Group serves a wide client base comprising tertiary Grade-A general hospitals, regional medical centers, specialized medical facilities, public health institutions, healthcare construction contractors, and pharmaceutical manufacturing facilities across mainland China. In recent strategic developments, the company completed its initial public offering on the ChiNext board of the Shenzhen Stock Exchange under ticker 301515, directing proceeds toward the construction of the Gangtong Smart Medical Equipment Production Base and upgrades to its centralized research and development facilities. To accelerate its digital healthcare expansion, the company established controlling subsidiaries including Gangtong Zhilian Digital Technology (Chongqing) Co., Ltd., focusing on hospital informatization, healthcare IoT, and big data management software, as well as Chengdu Deeprui Technology Co., Ltd., dedicated to operating room digitalization, surgical automation, and intelligent medical systems. In addition, the company expanded its pharmaceutical engineering capabilities through Gangtong Medical Group Pharmaceutical Equipment (Hebei) Co., Ltd., committed RMB 150 million as a limited partner to establish the Chengdu Rongchuang Gangtong Equity Investment Fund targeting high-end medical devices, medical robotics, and artificial intelligence healthcare technologies, and served as a lead drafting enterprise for the Chinese national technical standard GB/T 45898.1-2025 governing medical gas pipeline system terminal units.